Autonomy of Patients With Type 2 Diabetes With an Insulin Pump Device
Identifieur interne : 000123 ( Pmc/Curation ); précédent : 000122; suivant : 000124Autonomy of Patients With Type 2 Diabetes With an Insulin Pump Device
Auteurs : Yves Reznik [France] ; Rémy Morello [France] ; Amel Zenia [France] ; Julia Morera [France] ; Anne Rod [France] ; Michael Joubert [France]Source :
- Journal of Diabetes Science and Technology [ 1932-2968 ] ; 2014.
Abstract
Insulin pump therapy may be offered to patients with type 2 diabetes that is not controlled by multiple daily injections. Patients with type 2 diabetes may suffer from unrecognized cognitive disabilities, which may compromise the use of a pump device.
To predict patient autonomy, we evaluated 39 patients with type 2 diabetes from our database (n = 143) after continuous subcutaneous insulin infusion (CSII) initiation using (1) an autonomy questionnaire evaluating the patient’s cognitive and operative capacities for CSII utilization, (2) the Montreal Cognitive Assessment (MOCA) for the detection of mild cognitive disabilities, (3) the Hospital Anxiety and Depression Scale (HADS) for the detection of anxiety and depression, and (4) the Diabetes Treatment Satisfaction Questionnaire (DTSQ). Patients were selected to constitute 3 groups matched for age, with different degrees of autonomy at discharge after the initial training program: complete (n = 13), partial (n = 13), or no autonomy (n = 13).
The satisfaction level with the pump device was high. At the last follow-up visit, only 23% of patients did not reach complete autonomy. The autonomy score correlated fairly with the MOCA score (
Patients with type 2 diabetes with partial autonomy at discharge may progress to complete autonomy. The MOCA and HADS may help predict a patient’s ability to manage with a pump device.
Url:
DOI: 10.1177/1932296814533171
PubMed: 24876438
PubMed Central: 4764221
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000123
Links to Exploration step
PMC:4764221Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Autonomy of Patients With Type 2 Diabetes With an Insulin Pump Device</title>
<author><name sortKey="Reznik, Yves" sort="Reznik, Yves" uniqKey="Reznik Y" first="Yves" last="Reznik">Yves Reznik</name>
<affiliation wicri:level="1"><nlm:aff id="aff1-1932296814533171">Endocrinology and Diabetes Department, CHU Côte de Nacre, Caen Cedex, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Endocrinology and Diabetes Department, CHU Côte de Nacre, Caen Cedex</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Morello, Remy" sort="Morello, Remy" uniqKey="Morello R" first="Rémy" last="Morello">Rémy Morello</name>
<affiliation wicri:level="1"><nlm:aff id="aff2-1932296814533171">Biostatistic and Clinical Research Department, CHU Côte de Nacre, Caen Cedex, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Biostatistic and Clinical Research Department, CHU Côte de Nacre, Caen Cedex</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Zenia, Amel" sort="Zenia, Amel" uniqKey="Zenia A" first="Amel" last="Zenia">Amel Zenia</name>
<affiliation wicri:level="1"><nlm:aff id="aff1-1932296814533171">Endocrinology and Diabetes Department, CHU Côte de Nacre, Caen Cedex, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Endocrinology and Diabetes Department, CHU Côte de Nacre, Caen Cedex</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Morera, Julia" sort="Morera, Julia" uniqKey="Morera J" first="Julia" last="Morera">Julia Morera</name>
<affiliation wicri:level="1"><nlm:aff id="aff1-1932296814533171">Endocrinology and Diabetes Department, CHU Côte de Nacre, Caen Cedex, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Endocrinology and Diabetes Department, CHU Côte de Nacre, Caen Cedex</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Rod, Anne" sort="Rod, Anne" uniqKey="Rod A" first="Anne" last="Rod">Anne Rod</name>
<affiliation wicri:level="1"><nlm:aff id="aff1-1932296814533171">Endocrinology and Diabetes Department, CHU Côte de Nacre, Caen Cedex, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Endocrinology and Diabetes Department, CHU Côte de Nacre, Caen Cedex</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Joubert, Michael" sort="Joubert, Michael" uniqKey="Joubert M" first="Michael" last="Joubert">Michael Joubert</name>
<affiliation wicri:level="1"><nlm:aff id="aff1-1932296814533171">Endocrinology and Diabetes Department, CHU Côte de Nacre, Caen Cedex, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Endocrinology and Diabetes Department, CHU Côte de Nacre, Caen Cedex</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">24876438</idno>
<idno type="pmc">4764221</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764221</idno>
<idno type="RBID">PMC:4764221</idno>
<idno type="doi">10.1177/1932296814533171</idno>
<date when="2014">2014</date>
<idno type="wicri:Area/Pmc/Corpus">000123</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000123</idno>
<idno type="wicri:Area/Pmc/Curation">000123</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000123</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Autonomy of Patients With Type 2 Diabetes With an Insulin Pump Device</title>
<author><name sortKey="Reznik, Yves" sort="Reznik, Yves" uniqKey="Reznik Y" first="Yves" last="Reznik">Yves Reznik</name>
<affiliation wicri:level="1"><nlm:aff id="aff1-1932296814533171">Endocrinology and Diabetes Department, CHU Côte de Nacre, Caen Cedex, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Endocrinology and Diabetes Department, CHU Côte de Nacre, Caen Cedex</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Morello, Remy" sort="Morello, Remy" uniqKey="Morello R" first="Rémy" last="Morello">Rémy Morello</name>
<affiliation wicri:level="1"><nlm:aff id="aff2-1932296814533171">Biostatistic and Clinical Research Department, CHU Côte de Nacre, Caen Cedex, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Biostatistic and Clinical Research Department, CHU Côte de Nacre, Caen Cedex</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Zenia, Amel" sort="Zenia, Amel" uniqKey="Zenia A" first="Amel" last="Zenia">Amel Zenia</name>
<affiliation wicri:level="1"><nlm:aff id="aff1-1932296814533171">Endocrinology and Diabetes Department, CHU Côte de Nacre, Caen Cedex, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Endocrinology and Diabetes Department, CHU Côte de Nacre, Caen Cedex</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Morera, Julia" sort="Morera, Julia" uniqKey="Morera J" first="Julia" last="Morera">Julia Morera</name>
<affiliation wicri:level="1"><nlm:aff id="aff1-1932296814533171">Endocrinology and Diabetes Department, CHU Côte de Nacre, Caen Cedex, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Endocrinology and Diabetes Department, CHU Côte de Nacre, Caen Cedex</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Rod, Anne" sort="Rod, Anne" uniqKey="Rod A" first="Anne" last="Rod">Anne Rod</name>
<affiliation wicri:level="1"><nlm:aff id="aff1-1932296814533171">Endocrinology and Diabetes Department, CHU Côte de Nacre, Caen Cedex, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Endocrinology and Diabetes Department, CHU Côte de Nacre, Caen Cedex</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Joubert, Michael" sort="Joubert, Michael" uniqKey="Joubert M" first="Michael" last="Joubert">Michael Joubert</name>
<affiliation wicri:level="1"><nlm:aff id="aff1-1932296814533171">Endocrinology and Diabetes Department, CHU Côte de Nacre, Caen Cedex, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Endocrinology and Diabetes Department, CHU Côte de Nacre, Caen Cedex</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of Diabetes Science and Technology</title>
<idno type="eISSN">1932-2968</idno>
<imprint><date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><sec id="section1-1932296814533171"><title>Background:</title>
<p>Insulin pump therapy may be offered to patients with type 2 diabetes that is not controlled by multiple daily injections. Patients with type 2 diabetes may suffer from unrecognized cognitive disabilities, which may compromise the use of a pump device.</p>
</sec>
<sec id="section2-1932296814533171"><title>Methods:</title>
<p>To predict patient autonomy, we evaluated 39 patients with type 2 diabetes from our database (n = 143) after continuous subcutaneous insulin infusion (CSII) initiation using (1) an autonomy questionnaire evaluating the patient’s cognitive and operative capacities for CSII utilization, (2) the Montreal Cognitive Assessment (MOCA) for the detection of mild cognitive disabilities, (3) the Hospital Anxiety and Depression Scale (HADS) for the detection of anxiety and depression, and (4) the Diabetes Treatment Satisfaction Questionnaire (DTSQ). Patients were selected to constitute 3 groups matched for age, with different degrees of autonomy at discharge after the initial training program: complete (n = 13), partial (n = 13), or no autonomy (n = 13).</p>
</sec>
<sec id="section3-1932296814533171"><title>Results:</title>
<p>The satisfaction level with the pump device was high. At the last follow-up visit, only 23% of patients did not reach complete autonomy. The autonomy score correlated fairly with the MOCA score (<italic>R</italic>
= 0.771, <italic>P</italic>
< .001). A receiver operating characteristic (ROC) analysis showed that at a cut-off score of 24, the MOCA identified autonomous versus dependent patients at long-term follow-up (area under the ROC curve [AUC], 0.893; sensitivity, 81%; specificity, 81%). The HADS correlated negatively with the autonomy score, and the sociocultural level also influenced autonomy with pump utilization.</p>
</sec>
<sec id="section4-1932296814533171"><title>Conclusion:</title>
<p>Patients with type 2 diabetes with partial autonomy at discharge may progress to complete autonomy. The MOCA and HADS may help predict a patient’s ability to manage with a pump device.</p>
</sec>
</div>
</front>
</TEI>
<pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">J Diabetes Sci Technol</journal-id>
<journal-id journal-id-type="iso-abbrev">J Diabetes Sci Technol</journal-id>
<journal-id journal-id-type="publisher-id">DST</journal-id>
<journal-id journal-id-type="hwp">spdst</journal-id>
<journal-title-group><journal-title>Journal of Diabetes Science and Technology</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-2968</issn>
<publisher><publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">24876438</article-id>
<article-id pub-id-type="pmc">4764221</article-id>
<article-id pub-id-type="doi">10.1177/1932296814533171</article-id>
<article-id pub-id-type="publisher-id">10.1177_1932296814533171</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group><article-title>Autonomy of Patients With Type 2 Diabetes With an Insulin Pump Device</article-title>
<subtitle>Is It Predictable?</subtitle>
</title-group>
<contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Reznik</surname>
<given-names>Yves</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1932296814533171">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Morello</surname>
<given-names>Rémy</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-1932296814533171">2</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Zenia</surname>
<given-names>Amel</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1932296814533171">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Morera</surname>
<given-names>Julia</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1932296814533171">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Rod</surname>
<given-names>Anne</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1932296814533171">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Joubert</surname>
<given-names>Michael</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1932296814533171">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-1932296814533171"><label>1</label>
Endocrinology and Diabetes Department, CHU Côte de Nacre, Caen Cedex, France</aff>
<aff id="aff2-1932296814533171"><label>2</label>
Biostatistic and Clinical Research Department, CHU Côte de Nacre, Caen Cedex, France</aff>
<author-notes><corresp id="corresp1-1932296814533171">Yves Reznik, MD, Service d’Endocrinologie et Maladies Métaboliques, CHU Côte de Nacre, 14033 Caen Cedex, France Email: <email>reznik-y@chu-caen.fr</email>
</corresp>
</author-notes>
<pub-date pub-type="epub"><day>30</day>
<month>4</month>
<year>2014</year>
</pub-date>
<pub-date pub-type="collection"><month>7</month>
<year>2014</year>
</pub-date>
<volume>8</volume>
<issue>4</issue>
<fpage>760</fpage>
<lpage>765</lpage>
<permissions><copyright-statement>© 2014 Diabetes Technology Society</copyright-statement>
<copyright-year>2014</copyright-year>
<copyright-holder content-type="society">Diabetes Technology Society</copyright-holder>
</permissions>
<abstract><sec id="section1-1932296814533171"><title>Background:</title>
<p>Insulin pump therapy may be offered to patients with type 2 diabetes that is not controlled by multiple daily injections. Patients with type 2 diabetes may suffer from unrecognized cognitive disabilities, which may compromise the use of a pump device.</p>
</sec>
<sec id="section2-1932296814533171"><title>Methods:</title>
<p>To predict patient autonomy, we evaluated 39 patients with type 2 diabetes from our database (n = 143) after continuous subcutaneous insulin infusion (CSII) initiation using (1) an autonomy questionnaire evaluating the patient’s cognitive and operative capacities for CSII utilization, (2) the Montreal Cognitive Assessment (MOCA) for the detection of mild cognitive disabilities, (3) the Hospital Anxiety and Depression Scale (HADS) for the detection of anxiety and depression, and (4) the Diabetes Treatment Satisfaction Questionnaire (DTSQ). Patients were selected to constitute 3 groups matched for age, with different degrees of autonomy at discharge after the initial training program: complete (n = 13), partial (n = 13), or no autonomy (n = 13).</p>
</sec>
<sec id="section3-1932296814533171"><title>Results:</title>
<p>The satisfaction level with the pump device was high. At the last follow-up visit, only 23% of patients did not reach complete autonomy. The autonomy score correlated fairly with the MOCA score (<italic>R</italic>
= 0.771, <italic>P</italic>
< .001). A receiver operating characteristic (ROC) analysis showed that at a cut-off score of 24, the MOCA identified autonomous versus dependent patients at long-term follow-up (area under the ROC curve [AUC], 0.893; sensitivity, 81%; specificity, 81%). The HADS correlated negatively with the autonomy score, and the sociocultural level also influenced autonomy with pump utilization.</p>
</sec>
<sec id="section4-1932296814533171"><title>Conclusion:</title>
<p>Patients with type 2 diabetes with partial autonomy at discharge may progress to complete autonomy. The MOCA and HADS may help predict a patient’s ability to manage with a pump device.</p>
</sec>
</abstract>
<kwd-group><kwd>cognitive disability</kwd>
<kwd>DTSQ</kwd>
<kwd>HADS</kwd>
<kwd>insulin infusion system</kwd>
<kwd>MOCA</kwd>
<kwd>type 2 diabetes</kwd>
</kwd-group>
</article-meta>
</front>
</pmc>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Pmc/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000123 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd -nk 000123 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonFranceV1 |flux= Pmc |étape= Curation |type= RBID |clé= PMC:4764221 |texte= Autonomy of Patients With Type 2 Diabetes With an Insulin Pump Device }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Curation/RBID.i -Sk "pubmed:24876438" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd \ | NlmPubMed2Wicri -a ParkinsonFranceV1
This area was generated with Dilib version V0.6.29. |